Navigation Links
Islet Sciences, Inc. Technologies Featured in Five Separate Presentations at the American Diabetes Association Annual Meeting
Date:6/24/2013

p>The technologies presented at the ADA meeting have received grant support from Department of Defense, National Institute of Health, Juvenile Diabetes Research Foundation, as well as funding from Islet Sciences. 

About Islet Sciences, Inc.


Islet Sciences is a development-stage biotechnology company with patented technologies focused on infusion therapy for people with insulin-dependent diabetes.  The Company's infusion technology includes methods for the culturing, isolation, maturation, and immunoprotection (microencapsulation) of islet cells. The Company's mission includes the introduction of commercial products relevant to the insulin dependent diabetes marketplace including diagnostics and anti-inflammatory compounds. For more information: www.isletsciences.com

Forward-Looking Statements


This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements for Islet Sciences reflect current expectations, as of the date of this press release, and involve certain risks and uncertainties.   Actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors.  Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the risks described in the Islet Science's reports filed with the Securities and Exchange Commission.  The companies' further development is highly dependent on future medical and research developments and market acceptance, which is outside their control.

Investor Contact:
Jeff Ramson

ProActive Capital Group
646-863-6341
jramson@proactivecapital.com

Media Contact:
Sandra Lee
ProA
'/>"/>

SOURCE Islet Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Islet Sciences Announces Exclusive License Agreement with the University of California (UCLA) to Commercialize Small Molecules for Islet Expansion
2. Islet Sciences Announces Exclusive License Agreement with Winthrop University Hospital to Commercialize a Beta Cell Loss Measurement Technology in Diabetes
3. Islet Sciences Names Richard A. Franco, Sr. to its Board of Directors
4. Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology
5. Islet Sciences Announces DiaKine Therapeutics Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
6. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
7. Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal
8. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
9. MedeAnalytics Ken Perez Predicts Rapid Growth of Healthcare Data Analytics Market at Conference on Data Analytics in Life Sciences, Healthcare and Biotech Companies
10. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
11. VG Life Sciences, Inc. Secures Two-Year Funding Commitment and Administrative Support from MedBridge, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... TRIANGLE PARK, N.C. and ... agricultural research firm AgBiome, and Genective, key developer ... to accelerate the discovery of new generations of ... traits for insect control to counter the realities ... partner with Genective, aligning AgBiome,s unique insect control ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus ... the development of groundbreaking drugs to treat neurodegenerative ... today that Robert G. Miller , M.D., Director ... Sutter Health,s California Pacific Medical Center in San Francisco, ... Association for $1.5 million to help fund a ...
(Date:7/1/2015)... 2015 InferMed , ... will augment ... clinical s olutions suite   Elsevier ... products and services, announced today the acquisition of  InferMed , ... technology company. InferMed,s Arezzo technology supports clinicians in ...
(Date:6/30/2015)... Japan , July 1, 2015 R-Japan Co.,Ltd. ... on the Safety of Regenerative Medicine from the Ministry of ... on June 29, 2015. The fact that ... processing facility through the auditing from Pharmaceuticals and Medical Devices ... the application, allows it to provide stem cell manufacturing service ...
Breaking Biology Technology:AgBiome and Genective collaborate to create novel insect-resistant crops 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2
... , PALO ALTO, Calif., Aug. 17, 2009 ... with a focus on the NS4B Hepatitis C Virus (HCV) ... Board of Directors. , , Truex is ... private pharmaceutical company focused on the development of anti-inflammatory products ...
... , SAN DIEGO, Aug. 17 Imagenetix, ... natural-based, proprietary products announced that last week Dr. Robert Hesslink, ... on his Bloomberg Radio program, Taking Stock. Dr. Hesslink ... its flagship product, InflameAway Celadrin(R), and 1-TDC, Imagenetix,s early stage ...
... Inc. (NASDAQ: VSGN ; TSX:VAS), today announced that ... Department of The NASDAQ Stock Market indicating that Vasogen ... We plan to request a hearing before the NASDAQ ... determination of the continued listing of our common stock. ...
Cached Biology Technology:Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors 2Imagenetix, Inc. Announces Interview With Bloomberg Radio 2Vasogen Receives NASDAQ Notification Related to Minimum Bid Price 2
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
(Date:6/24/2015)... , June 24, 2015 The biologics safety ... major drivers for the market include growth of the ... new drug launches. Over the years, the number of ... 2001 and 2010, the FDA approved 225 drug applications ... WIPO, Europe accounted for 3,822 ...
(Date:6/23/2015)... , June 23, 2015   MedNet Solutions ... supports the entire spectrum of clinical research, is ... ™ , the company,s intuitive, flexible and ... a Silver 2015 Stevie® Award by the ... & Services Website category.  The American Business Awards ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... CORVALLIS, Ore. A laboratory study has shown for the ... are linked to a side-effect of some statin drugs - ... of the most widely prescribed drugs in the world, able ... of heart attacks or other cardiovascular events. However, their role ...
... dozen Ludwig scientists from around the world presented the ... this week,s American Association for Cancer Research (AACR) Annual ... program with important diagnostic and treatment implications for emerging ... available to help patients with melanoma, researchers are developing ...
... age at which a child with autism is diagnosed ... he or she exhibits, new research from the University ... poor nonverbal communication and repetitive behaviors, were associated with ... a study in the April issue of the ...
Cached Biology News:Co-Q10 deficiency may relate to concern with statin drugs, higher risk of diabetes 2Ludwig presents advancements in immunotherapy and epigenetics at the American Association for Cancer Research Annual Meeting 2In autism, age at diagnosis depends on specific symptoms 2